The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | L | Antineoplastic and immunomodulating agents | |
| 2 | L01 | Antineoplastic agents | |
| 3 | L01B | Antimetabolites | |
| 4 | L01BC | Pyrimidine analogues | |
| 5 | L01BC06 | Capecitabine |
| Active Ingredient | Description | |
|---|---|---|
| Capecitabine |
Capecitabine is a non-cytotoxic fluoropyrimidine carbamate, which functions as an orally administered precursor of the cytotoxic moiety 5-fluorouracil (5-FU). There is evidence that the metabolism of 5-FU in the anabolic pathway blocks the methylation reaction of deoxyuridylic acid to thymidylic acid, thereby interfering with the synthesis of deoxyribonucleic acid (DNA). The incorporation of 5-FU also leads to inhibition of RNA and protein synthesis. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| CAPECITABINE ACCORD Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
| ECANSYA Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
| KAPETRAL Film-coated tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| Xeloda 150mg and 500mg Film-coated Tablets | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
